Argent BioPharma Limited (ASX:RGT), an innovative multidisciplinary drug discovery company within the biopharmaceutical sector, has announced the publication of its Company Presentation for June 2024:
Argent BioPharma is a Clinical-Stage, Revenue Generating Biopharmaceutical Company committed to providing accessible medical treatments for unmet medical needs, to bridge the gap where medical solutions currently fall short.
